Literature DB >> 20065944

Selective intrarenal human A1 adenosine receptor overexpression reduces acute liver and kidney injury after hepatic ischemia reperfusion in mice.

Sang Won Park1, Sean W C Chen, Mihwa Kim, Vivette D D'Agati, H Thomas Lee.   

Abstract

Acute kidney injury (AKI) is frequent after liver ischemia reperfusion (IR) can potentiate liver injury and is often complicated by subsequent multiorgan dysfunction syndrome. AKI because of liver IR is characterized by early renal endothelial cell apoptosis and impaired vascular integrity with subsequent neutrophil infiltration, proximal tubule necrosis/inflammation, and filamentous (F) actin disintegration. We tested whether selective renal overexpression of human A(1) adenosine receptors (huA(1)AR) protects against both liver and kidney injury sustained after liver IR. Mice were subjected to liver IR or to sham surgery 48 h after unilateral intrarenal injection of lentivirus encoding enhanced green fluorescent protein (EGFP) or EGFP-huA(1)AR. Intrarenal lentiviral gene delivery caused a robust transgene expression in the injected kidney without significant expression in the contralateral kidney or in the liver. Mice injected with EGFP-huA(1)AR lentivirus were protected against hepatic IR-induced liver and kidney injury with reduced necrosis, inflammation, and apoptosis, and better preserved F-actin and vascular permeability compared with mice injected with EGFP lentivirus. Importantly, we show that removing the EGFP-huA(1)AR lentivirus-injected kidney before hepatic ischemia abolished both renal and hepatic protection after liver IR showing that the overexpression of huA(1)AR in the injected kidney has a crucial role in protecting the kidney and liver after liver IR. Therefore, our findings show that protecting the kidney reduces liver IR injury and selective overexpression of cytoprotective A(1)ARs in the kidney leads to protection of both liver and kidney after hepatic IR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065944     DOI: 10.1038/labinvest.2009.143

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

Review 3.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

Review 4.  Adenosine and protection from acute kidney injury.

Authors:  Steven C Yap; H Thomas Lee
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

Review 5.  Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma.

Authors:  Yang Li; Annette Palmer; Ludmila Lupu; Markus Huber-Lang
Journal:  Eur J Trauma Emerg Surg       Date:  2022-07-14       Impact factor: 2.374

6.  Ischemic postconditioning prevents renal ischemia reperfusion injury through the induction of heat shock proteins in rats.

Authors:  Qiongmei Guo; Xuefang Du; Yanli Zhao; Dong Zhang; Lihui Yue; Zhenxian Wang
Journal:  Mol Med Rep       Date:  2014-10-14       Impact factor: 2.952

7.  Suppressed renoprotective purines in COVID-19 patients with acute kidney injury.

Authors:  Edwin K Jackson; Georgios D Kitsios; Michael Y Lu; Caitlin M Schaefer; Cathy J Kessinger; Bryan J McVerry; Alison Morris; Bernard J C Macatangay
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

Review 8.  Literature review of the mechanisms of acute kidney injury secondary to acute liver injury.

Authors:  Esther Platt; Enriko Klootwijk; Alan Salama; Brian Davidson; Francis Robertson
Journal:  World J Nephrol       Date:  2022-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.